Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program | MicrobiomeTrials← Back to trialsNCT06636383
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
RecruitingOBSERVATIONAL
Trial Details
Start: 2024-11-04Est. Completion: 2036-12
Enrollment target: 140 participants Locations- Children's Hospital of Orange County, Orange, California, United States
- Children's Hospital Colorado, Denver, Colorado, United States
- University of Connecticut Health Center, Hartford, Connecticut, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Duke University Medical Center, Durham, North Carolina, United States
- The Cleveland Clinic Foundation, Cleveland, Ohio, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- University of Texas Health Science Center at Houston, Houston, Texas, United States
- Primary Children's Hospital, Salt Lake City, Utah, United States
- Hospital de Clinicas de Porto Alegre (HCPA) - PPDS, Porto Alegre, Rio Grande do Sul, Brazil
- McGill University Health Center, Montreal, Quebec, Canada
- Rigshospitalet, Copenhagen, Denmark
- Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany
- University of Naples, Naples, Campania, Italy
- Istituto G Gaslini Ospedale Pediatrico IRCCS, Genoa, Italy
- Osaka City General Hospital, Osaka, Japan
- Fujita Health University Hospital, Toyoake, Japan
- Groningen University, Groningen, Provincie Groningen, Netherlands
- Hospital Clínico Universitario de Santiago, Santiago, Spain
Other microbiome trials you might be interested in
Glycogen Storage Disease Type IIPompe Disease
The Pompe Registry is a global, multicenter, international, longitudinal, observational, and voluntary program for patie…
Birmingham, United StatesEst. completion Jan 31, 2034
Glycogen Storage Disease Type I
The aim of this observational study is to evaluate the impact of raw cornstarch supplementation on postprandial glycemic…
Naples, ItalyEst. completion Dec 2026